Pfizer eyes digital AERS technology

Share this article:
Pfizer is experimenting with electronic medical records and mobile technology to detect safety issues sooner.
The company is partnering with Sermo, Epocrates and Brigham and Women's Hospital in Boston on projects aimed at making it easier for doctors to report adverse events information or ask questions about Pfizer medications, according to a Dow Jones report.

A collaboration with Harvard-affiliated Brigham and Women's Hospital, codenamed “Aster” (Adverse drug event Spontaneous Triggered Event Reporting), uses automated prompts in the hospital's computer system to encourage adverse event reporting—when, for example, a doctor changes the dosage of a drug.

That data is then automatically passed on to FDA and the companies. The system also collects more information about a patient's background in order to make it easier to determine whether an adverse event was caused by a drug or some other factor.

“We essentially demonstrated that you could make it easier for physicians to report adverse events thorough leveraging the electronic record,” Pfizer chief medical officer Freda Lewis-Hall told Dow Jones.

Pfizer has also placed a “contact manufacturer” button on Epocrates' mobile reference app, used by 275,000 physicians, which allows them to contact Pfizer's medical affairs department directly, via phone or email, to ask questions about Pfizer products.

Companies can segment that feature, said an Epocrates spokeswoman, so that it only appears to, say, high-decile prescribers (though Pfizer doesn't do so).

Similarly, Sermo has added a feature making it easier for its physician members to contact Pfizer with questions about its medicines.
Share this article:

Email Newsletters

More in Features

Antidote: On Cystic Fibrosis treatments

Antidote: On Cystic Fibrosis treatments

Recent treatments in CF, including the inhaled antibiotic Tobramycin, have increased lifespan well into adulthood.

The $3 generic and the $1,000 pill: pharma outsiders just don't get it

The $3 generic and the $1,000 pill: pharma ...

What do you call the people who treat medical breakthroughs as if they were bank heists? Malicious? Uninformed? Not with it?

Leadership Exchange Uncut : The Agency-Client Relationship

Leadership Exchange Uncut : The Agency-Client Relationship

Click the above link to access MM&M's first Leadership Exchange Uncut e-book, "The Agency-Client Relationship"